about
Cytidine deamination induced HIV-1 drug resistanceReduced Ribavirin Antiviral Efficacy via Nucleoside Transporter-Mediated Drug ResistanceHIV-1 RT Inhibitors with a Novel Mechanism of Action: NNRTIs that Compete with the Nucleotide SubstrateComparison of classifier fusion methods for predicting response to anti HIV-1 therapyDynamics of HIV-1 quasispecies during antiviral treatment dissected using ultra-deep pyrosequencingLikely role of APOBEC3G-mediated G-to-A mutations in HIV-1 evolution and drug resistancePrevalence of transmitted drug resistance and impact of transmitted resistance on treatment success in the German HIV-1 Seroconverter CohortThe challenge of HIV-1 antiretroviral resistance in Africa in the era of HAART.A classification approach for genotyping viral sequences based on multidimensional scaling and linear discriminant analysis.Alternative methods to analyse the impact of HIV mutations on virological response to antiviral therapyHost sequence motifs shared by HIV predict response to antiretroviral therapyPairwise and higher-order correlations among drug-resistance mutations in HIV-1 subtype B protease.RT-SHIV subpopulation dynamics in infected macaques during anti-HIV therapy.Generation of random mutant libraries with multiple primers in a single reactionA decade of viral mutations and associated drug resistance in a population of HIV-1+ Puerto Ricans: 2002-2011Distinct resistance mutation and polymorphism acquisition in HIV-1 protease of subtypes B and F1 from children and adult patients under virological failure.Transmitted antiretroviral drug resistance among acute and recent HIV infections in North Carolina from 1998 to 2007Drug-associated changes in amino acid residues in Gag p2, p7(NC), and p6(Gag)/p6(Pol) in human immunodeficiency virus type 1 (HIV-1) display a dominant effect on replicative fitness and drug response.Characterization of drug-resistance mutations in HIV type 1 isolates from drug-naive and ARV-treated patients in Bulgaria.HIV-1 reverse transcriptase connection subdomain mutations reduce template RNA degradation and enhance AZT excisionEvolution and recombination of genes encoding HIV-1 drug resistance and tropism during antiretroviral therapyTransmitted drug resistance and phylogenetic relationships among acute and early HIV-1-infected individuals in New York City.Retrospective analysis of the HIV-1 reverse transcriptase inhibitors' resistance in Silesia, PolandMutations in multiple domains of Gag drive the emergence of in vitro resistance to the phosphonate-containing HIV-1 protease inhibitor GS-8374.Bayesian network analyses of resistance pathways against efavirenz and nevirapine.Silent mutations are selected in HIV-1 reverse transcriptase and affect enzymatic efficiency."One pill, once daily": what clinicians need to know about Atriplatrade mark.5-year survival of patients with AIDS receiving antiretroviral therapy in HaitiVirologic response to lopinavir-ritonavir-based antiretroviral regimens in a multicenter international clinical cohort: comparison of genotypic interpretation scores.Prevalence of drug-resistant HIV-1 in rural areas of Hubei province in the People's Republic of China.Nucleoside and nucleotide analogs select in culture for different patterns of drug resistance in human immunodeficiency virus types 1 and 2.Canadian consensus guidelines for the optimal use of etravirine in the treatment of HIV-infected adults.Selecting anti-HIV therapies based on a variety of genomic and clinical factors.Viral resuppression and detection of drug resistance following interruption of a suppressive non-nucleoside reverse transcriptase inhibitor-based regimenTransmitted HIV drug resistance in treatment-naive Romanian patientsIn vitro characterization of MK-1439, a novel HIV-1 nonnucleoside reverse transcriptase inhibitor.RNA Viruses and RNAi: Quasispecies Implications for Viral Escape2014 Update of the drug resistance mutations in HIV-1Novel Mutations L228I and Y232H Cause Nonnucleoside Reverse Transcriptase Inhibitor Resistance in Combinational PatternEnfuvirtide antiretroviral therapy in HIV-1 infection.
P2860
Q24657298-DA05F99C-A0C7-44A5-B236-78642C156C91Q27488307-5A404B45-B621-4CC9-85E3-C378BBC0CE3DQ28250395-15CC66D2-FC32-4794-BAC6-2044F81CF643Q28473854-A536290B-333F-40E1-8A0F-9551C6081EB7Q28474783-A4537FD5-FA24-4BDC-8D12-DBE2B561A67BQ28475150-915088A0-3961-4426-8295-8C1F0830C48AQ28475698-31120AE1-D9E5-41DC-8732-E9F514C8C7E2Q30425595-D32E2BFC-57A9-4284-8717-3E944B7213D6Q30496509-9324B0DC-4B76-4DFB-9E55-050873F1DE53Q33378828-FC0401EA-137E-4712-AE22-2C7386B419AEQ33486144-ADC795E2-3F12-4F61-B5BD-0DE39270D7A5Q33503921-C76B0E3B-F8A5-462C-8BFA-F32A8AFD0F78Q33514943-C859253A-D384-48E8-821A-9B88C16EDAB3Q33548933-1D1B03B7-C5D2-4D3B-B6A1-2C403A1E0DC9Q33664179-B00A1CAA-7E42-4041-A69F-603DFC1EE86FQ33786428-3A01A0BE-04D9-41CF-BACF-9D576626D039Q33814896-367637C8-1BB5-4DDF-9E9D-4252494291BAQ34012585-EE3B73E4-8EE9-461D-B42C-9D57FC3DE479Q34083250-58841587-9941-43F8-B99A-0AE19D6A0335Q34802871-39A6A215-3D9C-4124-A57B-1586C66AAA0CQ35264750-36596941-15E5-4FED-B464-E1F61C8B1C23Q36188421-96A66E0E-90CD-453E-AF1D-19DA0F82EB5BQ36473782-E41481D1-3567-4631-89F6-24D80500E690Q36506829-77BD6A65-DD63-49F4-BAC1-B5AA397C6C46Q36677558-ADCBAAEB-69E0-4DBC-AD7A-58BE2FC63AB7Q36791067-97230F84-83CD-4853-BA0A-0647AD20089FQ36823570-3E94EE89-58BE-4AB6-8ECA-3708A45B7A5FQ36914062-B9AF0032-F5D6-44B3-9BBF-9F01513C7D81Q36949513-B32F6F35-6A24-4A1C-A849-66D4ECB28F9FQ36989316-B66D54B1-A157-4017-8BC5-E929479CFEDCQ37072022-F57EEB0D-313D-4FD2-B848-D521A93290F9Q37252113-AA750C5B-F49C-42DA-8D8D-CDABBD54839FQ37283246-75CA79B6-8ED8-417F-AC37-342EA0E4B281Q37351208-B92035AE-5EA6-4370-AB1E-788FF56A7AB5Q37495405-0838ADDC-82F2-45ED-B7FC-5F53380C4662Q37643598-EE4334C8-2AF6-44F8-BE7B-E553924C496AQ38535397-4BFBBDD5-CC49-4FBF-AE3B-61A5FF452325Q39498339-C4576209-8AFD-4C89-A8D0-B2E9ED65A640Q39627546-3A9E3362-10CE-4EBF-84EF-722CF5F3E7DFQ41715047-071BB5B6-4FBD-4978-A651-9EE0AC8E375F
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Update of the drug resistance mutations in HIV-1: 2007.
@en
type
label
Update of the drug resistance mutations in HIV-1: 2007.
@en
prefLabel
Update of the drug resistance mutations in HIV-1: 2007.
@en
P2093
P50
P1476
Update of the drug resistance mutations in HIV-1: 2007
@en
P2093
Bonaventura Clotet
Daniel R Kuritzkes
Deenan Pillay
Douglas D Richman
Françoise Brun-Vézinet
Jonathan M Schapiro
Victoria A Johnson
P304
P577
2007-08-01T00:00:00Z